JPS5993032A - 安定なイソソルビド硝酸エステルの包接化合物 - Google Patents
安定なイソソルビド硝酸エステルの包接化合物Info
- Publication number
- JPS5993032A JPS5993032A JP57200268A JP20026882A JPS5993032A JP S5993032 A JPS5993032 A JP S5993032A JP 57200268 A JP57200268 A JP 57200268A JP 20026882 A JP20026882 A JP 20026882A JP S5993032 A JPS5993032 A JP S5993032A
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- isosorbidnitrate
- nitrate
- inclusion compound
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 30
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910002651 NO3 Inorganic materials 0.000 claims description 23
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 18
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims 1
- 229960002479 isosorbide Drugs 0.000 claims 1
- 229960004853 betadex Drugs 0.000 abstract description 12
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- -1 dinitro ester Chemical class 0.000 abstract description 10
- 239000002904 solvent Substances 0.000 abstract description 5
- 230000007794 irritation Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 238000002347 injection Methods 0.000 abstract description 3
- 150000002148 esters Chemical class 0.000 abstract description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 abstract description 2
- 229920001542 oligosaccharide Polymers 0.000 abstract description 2
- 239000006190 sub-lingual tablet Substances 0.000 abstract description 2
- 230000000304 vasodilatating effect Effects 0.000 abstract description 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 abstract 1
- 150000000779 D-glucopyranoses Chemical group 0.000 abstract 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 229940126701 oral medication Drugs 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229940098466 sublingual tablet Drugs 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- YWXYYJSYQOXTPL-JGWLITMVSA-N [(3r,3ar,6s,6as)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-JGWLITMVSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000008187 granular material Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000004455 differential thermal analysis Methods 0.000 description 4
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000002411 thermogravimetry Methods 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007416 differential thermogravimetric analysis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 229950004152 insulin human Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57200268A JPS5993032A (ja) | 1982-11-17 | 1982-11-17 | 安定なイソソルビド硝酸エステルの包接化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57200268A JPS5993032A (ja) | 1982-11-17 | 1982-11-17 | 安定なイソソルビド硝酸エステルの包接化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5993032A true JPS5993032A (ja) | 1984-05-29 |
JPH0246020B2 JPH0246020B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-10-12 |
Family
ID=16421501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57200268A Granted JPS5993032A (ja) | 1982-11-17 | 1982-11-17 | 安定なイソソルビド硝酸エステルの包接化合物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5993032A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5692221A (en) * | 1979-12-26 | 1981-07-25 | Zeria Shinyaku Kogyo Kk | Stable clathrate compound of trolnitrate, and its preparation |
-
1982
- 1982-11-17 JP JP57200268A patent/JPS5993032A/ja active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5692221A (en) * | 1979-12-26 | 1981-07-25 | Zeria Shinyaku Kogyo Kk | Stable clathrate compound of trolnitrate, and its preparation |
Also Published As
Publication number | Publication date |
---|---|
JPH0246020B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2793280B2 (ja) | モルヒネ含有組成物 | |
DE69115229T2 (de) | Arzneimittel. | |
JPS63162627A (ja) | 徐放性医薬製剤 | |
US4254099A (en) | Pharmaceutical tablet composition | |
JPH06507913A (ja) | タキサン類の誘導体を基とする新規組成物 | |
HUT59821A (en) | Macrograin aerosole carriers and process for producing them | |
EA011275B1 (ru) | Суточная дозированная единица комплекса этинилэстрадиол-циклодекстрин | |
JP6641062B2 (ja) | テコビリマットの経口用医薬組成物及びその調製法 | |
KR950013752B1 (ko) | 분무 건조된 아세트아미노펜의 치료용 분말, 이의 제조방법 및 이를 함유하는 약제학적 제형 | |
JPS599539B2 (ja) | ニトログリセリン水溶液及びその製造法 | |
HU194285B (en) | Process for preparing inclusion compound formed from 2-/nitrooxymethyl/-6-chlorpyridine and beta-cyclodextrin | |
JPH02149513A (ja) | 溶解率向上に適した形態のポリマー基剤に担持させた低溶解性薬剤およびその製造方法 | |
JPH10203985A (ja) | 抗菌活性キノロン誘導体の味覚掩蔽製剤の製造 | |
JPS62123196A (ja) | プレドニゾロン包接化合物 | |
JPS5835967B2 (ja) | 微細結晶ワルフアリンの製造方法 | |
JPH029007B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
JPS5993032A (ja) | 安定なイソソルビド硝酸エステルの包接化合物 | |
JPH1171269A (ja) | 経口液体医薬製剤 | |
EP2444425A1 (de) | 1:1, 2:1- oder 3:1-Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem halogenierten Ether, seine Herstellung und seine Verwendung als Schlafmittel | |
JPH11189547A (ja) | 安定化されたニコランジル製剤及びその製造方法 | |
JP2603240B2 (ja) | ジヒドロピリジン−ヒドロキシプロピルシクロデキストリン包接複合体 | |
CN1646099A (zh) | 适于吸入的粉末制剂 | |
US3130126A (en) | Oral pharmaceutical products prepared with carboxymethyl benzyl dextran having a low carboxymethyl d. s. of 0.15 | |
RU2195292C1 (ru) | Фармацевтическая композиция, обладающая противоязвенным и антацидным действием | |
JPH0215522B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |